T80.82XA vs T86.0
T80.82XA (Complication of immune effector cellular therapy, initial encounter) compared with T86.0 (Complications of bone marrow transplant), from the official CMS tabular data. Both may be reported when both conditions are documented (Excludes2).
Can these codes be reported together?
Yes, when both are documented. T80.82XA carries an Excludes2 note covering T86.0: “complication of bone marrow transplant (T86.0)”
Excludes2 marks distinct conditions — both may be reported when both are documented.
Side by side
| T80.82XAComplication of immune effector cellular therapy, initial encounter | T86.0Complications of bone marrow transplant | |
|---|---|---|
| Billing status | Billable | Non-billable header |
| Classification | S00-T88 — Injury, Poisoning and Certain Other Consequences of External Causes (S00-T88) | S00-T88 — Injury, Poisoning and Certain Other Consequences of External Causes (S00-T88) |
| Definition | Complication of immune effector cellular therapy, initial encounter is a billable ICD-10-CM diagnosis code (T80.82A). | Complications of bone marrow transplant is a non-billable ICD-10-CM category code (T86.0). |
| 7th character | The appropriate 7th character is to be added to each code from category T80 | — |
| Includes | complications following perfusion Complication of chimeric antigen receptor (CAR-T) cell therapy Complication of IEC therapy | — |
| Use additional code | code to identify the specific complication, such as: cytokine release syndrome (D89.83-) immune effector cell-associated neurotoxicity syndrome (G92.0-) | code to identify other transplant complications, such as: graft-versus-host disease (D89.81-) malignancy associated with organ transplant (C80.2) |
Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources